Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.
about
FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic LeNovel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)Curing all patients with acute promyelocytic leukemia: are we there yet?Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia.The Future of Targeting FLT3 Activation in AML.Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemiaTreatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia.Survival and treatment response in adults with acute promyelocytic leukemia treated with a modified International Consortium on Acute Promyelocytic Leukemia protocol.How I treat children and adolescents with acute promyelocytic leukaemia.Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia.Acute promyelocytic leukemia harbouring rare FLT3-TKD and WT1 mutations: A case report.FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis.FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia.The Impact of FLT3 Mutations on the Development of Acute Myeloid Leukemias.The clinical significance of FLT3 ITD mutation on the prognosis of adult acute promyelocytic leukemia.Acute WT1-positive promyelocytic leukemia with hypogranular variant morphology, bcr-3 isoform of PML-RARα and Flt3-ITD mutation: a rare case report.Early mortality in acute promyelocytic leukemia: Potential predictors.Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study.High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based RegimenThe novel three-way variant t(6;17;15)(p21;q21;q22) in acute promyelocytic leukemia with an FLT3-ITD mutation: A case reportAcute myeloid leukemia
P2860
Q27028163-5F3B5514-D6DC-484D-AE55-AFFD8ECEC60AQ27853031-800AF994-3F5C-49E7-A910-5C82ED4437D8Q28646898-293FF2FA-0313-4774-8C00-621508AA9CDBQ33613426-11676661-8998-4812-8F30-A34F10244DD0Q33800102-238A4181-D1DE-45B1-A462-456DB97A37A1Q34555386-A7C375FA-3CD4-4894-ABA5-7B938B85331CQ34754867-C3A9C60A-D236-48F1-8BD8-643090E19D4DQ35717816-F531AE9D-8C1A-4C51-8EB6-890C83DBD93EQ36220730-E6ECF122-C6F1-41DD-A9A8-B5C22B34AF8DQ37212864-D58B9C0C-E5BA-4199-A36F-64F7795DD426Q37429222-801D6E31-3CA2-40EA-AFA7-38FA1FDADFD9Q37451376-D7AA89E9-F751-4A0B-8F5B-9A1596574FE4Q37712353-0D4994CA-32DC-4B4F-8E6A-EBCDF149E511Q37718455-C1A7825A-20AE-4DFD-BF4F-B19FF3E241C2Q42271164-CE770F3F-5712-4570-9CB1-14614C681613Q42831333-E3F542A7-FD22-4205-B164-90C3BC0C885CQ42982146-41D2B389-EC61-4199-838F-E5E77422EFFEQ43070849-3B0DA2C0-6316-4DFE-BE86-7522E515C8D4Q47292792-AE92F1C9-A65F-4067-8895-9FC6F48638A7Q51167811-0DD8AC4D-D72F-4B97-B78F-9337D321A183Q52355167-A1DBD15E-215E-4234-A8AC-8904EC7CFC35Q53090417-A6D4823B-65EE-4C04-AFC9-D68972B9C91DQ57192691-B6492230-BDDE-460A-B54A-387E5DA2C4FEQ57788688-35A4B40A-3D35-45AB-8225-7F2B8ABB0A54Q58481761-D471443E-69FE-4FA7-BB04-EA5C14F359F4
P2860
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prognostic value of FLT3 mutat ...... nthracycline monochemotherapy.
@ast
Prognostic value of FLT3 mutat ...... nthracycline monochemotherapy.
@en
type
label
Prognostic value of FLT3 mutat ...... nthracycline monochemotherapy.
@ast
Prognostic value of FLT3 mutat ...... nthracycline monochemotherapy.
@en
prefLabel
Prognostic value of FLT3 mutat ...... nthracycline monochemotherapy.
@ast
Prognostic value of FLT3 mutat ...... nthracycline monochemotherapy.
@en
P2093
P2860
P1433
P1476
Prognostic value of FLT3 mutat ...... nthracycline monochemotherapy.
@en
P2093
Carmen Chillón
Edo Vellenga
Eva Barragán
Félix Manso
HOVON Groups
Javier López
José González-Campos
José Román-Gómez
Marcos González
Maria J Calasanz
P2860
P304
P356
10.3324/HAEMATOL.2011.044933
P577
2011-06-17T00:00:00Z